STP-322

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSTP-322
Drug Alias Namemulti-targeted siRNA therapeutic cocktail (Sirnaomics)STP-322
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSirnaomics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSirnaomics Ltd
Active IndicationsN/A
Inactive IndicationsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A